Forgot Password

  • Occams Business Research & Consulting Pvt. Ltd

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-2730816
  • Global Neurorehabilitation Devices Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: July 2016 | Report Code: HME-2730816

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Neuro rehabilitation is a multipart medical process which is used to assist the recovery from a nervous system injury and also helps to reduce or compensate for any functional alterations resulting from it. It uses various devices to offer a series of therapies from occupational to psychological, training patients in communication, mobility skills etc. The commonly treated diseases are stroke, Parkinson’s disease, multiple sclerosis and cerebral palsy. The global neuro rehabilitation devices market is expected to have a CAGR of 15.3% during the forecast period 2016-2023 The major factors driving the global neuro rehabilitation devices market are increasing awareness among the physicians with respect to these devices, rising incidences of neurological diseases and increasing geriatric population. As per Administration for community living, population aged 65 and above is estimated to reach more than 80 million by 2050, which is twice of what was estimated in 2012. This growth is leading to increased prevalence of neurological diseases. According to the Centers for Disease Control and Prevention, it has been estimated that almost 130,000 Americans die from stroke each year, i.e. an average of one person in America dies from stroke every 4 minutes. In addition, Asia Pacific accounts for two-third of the world’s disabled population and this number is expected to increase tremendously. The major reason for this is the alarmingly high road traffic fatality rates. Globally, Asia pacific accounts for highest percentage of traumatic brain injuries due to unintentional injuries, road traffic accidents and falls. This wide-spread prevalence of stroke and traumatic brain injuries, resulting in various neurological disorders, is estimated to impact the demand for neuro rehabilitation devices globally. Furthermore, emergence of wearable technology and robotics will have tremendous impact on the development of neuro rehabilitation devices, and will push the researchers and device manufacturers to bring new innovative products as per the global market needs. However, lack of skilled and trained professionals, various legislations and government regulations and high cost of treatment are few restraints that are hampering the growth of the global neuro rehabilitation devices market.

Source: OBRC Analysis

The global neuro rehabilitation devices market is segmented on the basis of product and applications. On the basis of product, the market is segmented into:

  • Neuro robotic systems
  • Brain computer interface
  • Non-invasive stimulators
  • Wearable device





On the basis of application segment, market is sub segmented into:

  • Stroke
  • Traumatic brain injury
  • Spinal cord injury
  • Parkinson’s
  • Cerebral palsy






The revenue for the above product and application segments is specific to the global neurorehabilitation devices market. However, the total revenue of these application and product in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up product and application segments.

Geographically, the global neuro rehabilitation devices market is segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America is the largest market of neuro rehabilitation devices due to increasing aging population, rising prevalence of neurological diseases and highly developed healthcare infrastructure in the region in comparison to any other. For instance, as per the U.S. Census Bureau, it has been estimated that approximately 20% of the U.S. population will be of age 65 years or above by 2030. Europe holds the second largest market share followed by Asia Pacific. Europe market is impacted by increasing geriatric population in the countries like UK, Germany etc. However, Asia Pacific is rising at a high CAGR due to large patient base, improving healthcare infrastructure and increasing government initiatives. APAC market will grow at a CAGR of around 18%during the forecast period of 2016- 2023.

In product segment, in 2015, neurorobotic system held the largest share for the global neuro rehabilitation devices market and is likely to retain its dominance during the forecast period. However, non-invasive brain stimulators, are estimated to witness the highest growth rate from 2016 to 2023. The application segment comprises of stroke market, traumatic brain injury market, spinal cord injury market, Parkinson’s market and cerebral palsy market. Treatment and therapies of Parkinson’s diseases is the fastest growing application area for this market owing to increasing prevalence of the diseases in the markets of the U.S., U.K., Iceland, Finland, and Ireland.

The major market players of the global neuro rehabilitation devices market are:

  • AGILIAD
  • BIONESS INC.
  • BIOXTREME ROBOTICS REHABILITATION
  • ST JUDE MEDICAL INC.
  • OTHERS






Detailed analysis of these companies provided in this report comprises of overview, SCOT analysis, product portfolio, strategic initiative and strategic analysis.

These companies use various strategies such as merger & acquisition, collaboration, partnership and product launching. In Feb 2017, Bioness launched the first series of successful Stim Router Neuromodulation system to further support clinicians who are looking to help their patients from long-term pain relief.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as product launch that is on February 2017, Bioness Inc, its first series of successful Stim Router Neuromodulation system.
  • Provide in detail the different segments such as products and application which affect the global neuro rehabilitation devices market.
  • Provide you the patent analysis of global neuro rehabilitation devices market.
  • Identify and understand the strengths, opportunities, challenges and threats of global neuro rehabilitation devices market.
  • Provide revenues of major players of the market such as Medtronic PLC, St Jude Medical Inc.
  • Provide you various regulatory policies which affect the global neuro rehabilitation devices market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global neurorehabilitation devices market offers the longest chain of market segmentation covering major segmentation based on products and applications. The report tracks the major market trends in the global neurorehabilitation market such as rising technological advancements and rising awareness for neurorehabilitation services is contributing to increasing adoption of these devices.   For each market segments covered in global neuro rehabilitation devices market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the neuro rehabilitation devices industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global neuro rehabilitation devices market:

  • North America had the largest revenue share in 2016.
  • Product Launch is the key strategy adopted by the various market players of global Neurorehabilitation Devices market.

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL NEUROREHAVILATION MARKET : EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. TOTAL MARKET ANALYSIS

2.4.1.        TOP 5 FINDINGS

2.4.2.        TOP 5 OPPORTUNITY MARKETS

2.4.3.        TOP 5 COMPANIES

2.4.4.        TOP 3 COMPETITIVE STRATEGIES

2.5. ESTIMATION ANALYSIS

2.6. STRATEGIC ANALYSIS

2.6.1.        INVESTMENT VS. ADOPTION MODEL

2.6.2.        360-DEGREE INDUSTRY ANALYSIS

2.6.3.        PORTERS 5 FORCE MODEL

2.6.4.        SEE-SAW ANALYSIS

2.6.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.7. COMPETITIVE ANALYSIS

2.7.1.        KEY STRATEGIES & ANALYSIS

2.7.2.        MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS

2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.8.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.8.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.8.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        INCREASING PREVALENCE OF  NEUROLOGICAL DISEASES

3.1.2.         EMERGENCE OF WEARABLE AND ROBOTICS

3.1.3.        INCREASING GERIATRIC POPULATION

3.1.4.        TECHNOLOGICAL ADVANCEMENTS

3.2.  MARKET RESTRAINTS

3.2.1.        HIGH COST OF TREATMENT

3.2.2.        LACK OF SKILLED AND TRAINED PROFESSIONALS

3.3. MARKET OPPORTUNITIES

3.4. INCREASING PATIENT BASE IN EMERGING ECONOMIES

3.5.   MARKET CHALLENGES

3.5.1.      VARIOUS LEGISLATIONS AND GOVERNMENT REGULATIONS

4.       GLOBAL NEUROREHAVILATION MARKET BY PRODUCT

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.  OPPORTUNITY MATRIX

4.5. MARKET SEGMENTATION

4.5.1.      GLOBAL NEUROROBOTIC SYSTEMS PRODCUT  MARKET

4.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.1.4.  KEY CONCLUSIONS

4.5.2.      GLOBAL BRAIN COMPUTER INTERFACE  PRODDUCT MARKET

4.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.2.4.  KEY CONCLUSIONS

4.5.3.      GLOBAL NON-INVASIVE STIMULATORS  PRODCUTS MARKET

4.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.3.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.3.4.  KEY CONCLUSIONS

4.6.                     GLOBAL WEARABLE DEVICE MARKET

4.6.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.6.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.6.1.3.  MARKET PARTICIPANTS AND PRODUCTS

4.6.1.4.  KEY CONCLUSIONS

 

5.      GLOBAL NEUROREHAVILATION MARKET BY APPLICATIONS

5.1. MARKET DEFINITION AND SCOPE

5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4.  OPPORTUNITY MATRIX

5.5. MARKET SEGMENTATION

5.5.1.      GLOBAL STROKE  APPLICATION MARKET

5.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.1.4.  KEY CONCLUSIONS

5.5.2.      GLOBAL TRAUMATIC BRAIN INJURY  APPLICATION MARKET

5.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.2.4.  KEY CONCLUSIONS

5.5.3.      GLOBAL SPINAL CORD INJURY APPLICATION  MARKET

5.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.3.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.3.4.  KEY CONCLUSIONS

5.5.4.      GLOBAL PARKINSON’S  DISEASE  APPLICATION MARKET

5.5.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.4.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.4.4.  KEY CONCLUSIONS

5.5.5.      GLOBAL CEREBRAL PALSY APPLICATION MARKET

5.5.5.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.5.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.5.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.5.4.  KEY CONCLUSIONS

5.6. GLOBAL NEUROREHAVILATION MARKET BY END USERS

5.7.  MARKET DEFINITION AND SCOPE

5.8. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.9. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.10.                   OPPORTUNITY MATRIX

5.11.                  MARKET SEGMENTATION

5.11.1.  GLOBAL COGNITIVE CARE CENTERS  END USER MARKET

5.11.1.1.                      ADOPTION SCENARIO & MARKET DETERMINANTS

5.11.1.2.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.11.1.3.                      MARKET PARTICIPANTS AND PRODUCTS

5.11.1.4.                      KEY CONCLUSIONS

5.11.2.  GLOBAL HOSPITALS/CLINICS  END USER MARKET

5.11.2.1.                      ADOPTION SCENARIO & MARKET DETERMINANTS

5.11.2.2.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.11.2.3.                      MARKET PARTICIPANTS AND PRODUCTS

5.11.2.4.                      KEY CONCLUSIONS

5.11.3.  GLOBAL RESEARCH INSTITUTES MARKET

5.11.3.1.                      ADOPTION SCENARIO & MARKET DETERMINANTS

5.11.3.2.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.11.3.3.                      MARKET PARTICIPANTS AND PRODUCTS

5.11.3.4.                      KEY CONCLUSIONS

5.11.4.  GLOBAL OTHERS MARKET

5.11.4.1.                      ADOPTION SCENARIO & MARKET DETERMINANTS

5.11.4.2.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.11.4.3.                      MARKET PARTICIPANTS AND PRODUCTS

5.11.4.4.                      KEY CONCLUSIONS

6.       COMPETITIVE LANDSCAPE

6.1. KEY STRATEGIES

6.1.1.        LIST OF MERGERS AND ACQUISITION

6.1.2.        LIST OF JOINT VENTURES

6.1.3.        LIST OF PRODUCT LAUNCHES

6.1.4.        LIST OF PARTNERSHIPS

7.       GEOGRAPHIC ANALYSIS

7.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

7.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

7.3. OPPORTUNITY MATRIX

7.4.                      GLOBAL NEUROREHAVILATION MARKET BY REGION 2015-2024  

7.4.1.      NORTH AMERICA

7.4.1.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

7.4.1.2.  TOP COUNTRY ANALYSIS

7.4.1.2.1.      U.S.

7.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.1.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.1.2.1.3.   KEY CONCLUSIONS

7.4.1.2.2.      CANADA

7.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.1.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.1.2.2.3.   KEY CONCLUSIONS

7.4.2.      EUROPE

7.4.2.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

7.4.2.2.  TOP COUNTRY ANALYSIS

7.4.2.2.1.      UK

7.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.2.2.1.3.   KEY CONCLUSIONS

7.4.2.2.2.      FRANCE

7.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.2.2.2.3.   KEY CONCLUSIONS

7.4.2.2.3.      GERMANY

7.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.3.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.2.2.3.3.   KEY CONCLUSIONS

7.4.2.2.4.      SPAIN

7.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.4.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.2.2.4.3.   KEY CONCLUSIONS

7.4.2.2.5.      REST OF EUROPE

7.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.5.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.2.2.5.3.   KEY CONCLUSIONS

7.4.3.      ASIA PACIFIC

7.4.3.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

7.4.3.2.  TOP COUNTRY ANALYSIS

7.4.3.2.1.      CHINA

7.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.3.2.1.3.   KEY CONCLUSIONS

7.4.3.2.2.      INDIA

7.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.3.2.2.3.   KEY CONCLUSIONS

7.4.3.2.3.      JAPAN

7.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.3.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.3.2.3.3.   KEY CONCLUSIONS

7.4.3.2.4.      AUSTRALIA

7.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.4.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.3.2.4.3.   KEY CONCLUSIONS

7.4.3.2.5.      REST OF ASIA PACIFIC

7.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.5.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.3.2.5.3.   KEY CONCLUSIONS

7.4.4.      ROW

7.4.4.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

7.4.4.2.  TOP COUNTRY ANALYSIS

7.4.4.2.1.      LATIN AMERICA

7.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.4.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.4.2.1.3.   KEY CONCLUSIONS

7.4.4.2.2.      MIDDLE EAST & AFRICA

7.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.4.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

7.4.4.2.2.3.   KEY CONCLUSIONS

8.       COMPANY PROFILES

8.1. AGILIAD (INDIA) 

8.1.1.        OVERVIEW

8.1.2.        PRODUCT PORTFOLIO

8.1.3.        STRATEGIC INITIATIVES

8.1.4.        SCOT ANALYSIS

8.1.5.        STRATEGIC ANALYSIS

8.2. ALTER G INC. (U.S.)

8.2.1.        OVERVIEW

8.2.2.        PRODUCT PORTFOLIO

8.2.3.        STRATEGIC INITIATIVES

8.2.4.        SCOT ANALYSIS

8.2.5.        STRATEGIC ANALYSIS

8.3. BIONESS INC. (U.S.)

8.3.1.        OVERVIEW

8.3.2.        PRODUCT PORTFOLIO

8.3.3.        STRATEGIC INITIATIVES

8.3.4.        SCOT ANALYSIS

8.3.5.        STRATEGIC ANALYSIS

8.4. BIONIK LABORATORIES CORP.  (CANADA)

8.4.1.        OVERVIEW

8.4.2.        PRODUCT PORTFOLIO

8.4.3.        STRATEGIC INITIATIVES

8.4.4.        SCOT ANALYSIS

8.4.5.        STRATEGIC ANALYSIS

8.5. BIOXTREME ROBOTICS REHABILITATION (ISRAEL)

8.5.1.        OVERVIEW

8.5.2.        PRODUCT PORTFOLIO

8.5.3.        STRATEGIC INITIATIVES

8.5.4.        SCOT ANALYSIS

8.5.5.        STRATEGIC ANALYSIS

8.6. DENECOR (SPAIN)

8.6.1.        OVERVIEW

8.6.2.        PRODUCT PORTFOLIO

8.6.3.        STRATEGIC INITIATIVES

8.6.4.        SCOT ANALYSIS

8.6.5.        STRATEGIC ANALYSIS

8.7. ECTRON (U.S.)

8.7.1.        OVERVIEW

8.7.2.        PRODUCT PORTFOLIO

8.7.3.        STRATEGIC INITIATIVES

8.7.4.        SCOT ANALYSIS

8.7.5.        STRATEGIC ANALYSIS

8.8. EKSO BIONICS HOLDING INC. (U.S.)

8.8.1.        OVERVIEW

8.8.2.        PRODUCT PORTFOLIO

8.8.3.        STRATEGIC INITIATIVES

8.8.4.        SCOT ANALYSIS

8.8.5.        STRATEGIC ANALYSIS

8.9. HOCOMA AG (SWITZERLAND)

8.9.1.        OVERVIEW

8.9.2.        PRODUCT PORTFOLIO

8.9.3.        STRATEGIC INITIATIVES

8.9.4.        SCOT ANALYSIS

8.9.5.        STRATEGIC ANALYSIS

8.10.                  HELIUS (U.S.)

8.10.1.   OVERVIEW

8.10.2.   PRODUCT PORTFOLIO

8.10.3.   STRATEGIC INITIATIVES

8.10.4.   SCOT ANALYSIS

8.10.5.   STRATEGIC ANALYSIS

8.11.                  KINESTICA (SLOVENIA)

8.11.1.   OVERVIEW

8.11.2.   PRODUCT PORTFOLIO

8.11.3.   STRATEGIC INITIATIVES

8.11.4.   SCOT ANALYSIS

8.11.5.   STRATEGIC ANALYSIS

8.12.                  MEDTRONIC PLC.    (U.S.)

8.12.1.   OVERVIEW

8.12.2.   PRODUCT PORTFOLIO

8.12.3.   STRATEGIC INITIATIVES

8.12.4.   SCOT ANALYSIS

8.12.5.   STRATEGIC ANALYSIS

8.13.                  NEUROSTYLE (SINGAPORE)

8.13.1.   OVERVIEW

8.13.2.   PRODUCT PORTFOLIO

8.13.3.   STRATEGIC INITIATIVES

8.13.4.   SCOT ANALYSIS

8.13.5.   STRATEGIC ANALYSIS

8.14.                  St JUDE MEDICAL INC.  (U.S.)

8.14.1.   OVERVIEW

8.14.2.   PRODUCT PORTFOLIO

8.14.3.   STRATEGIC INITIATIVES

8.14.4.   SCOT ANALYSIS

8.14.5.   STRATEGIC ANALYSIS

LIST OF TABLES

1.       GLOBAL NEUROREHAVILATION MARKET BY PRODUCT 2015-2024 ($ MILLION)

2.       GLOBAL NEUROROBOTIC SYSTEMS PRODUCT BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL BRAIN COMPUTER INTERFACE PRODUCTS MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL NON-INVASIVE STIMULATORS PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5.       GLOBAL WEARABLE DEVICE PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6.       GLOBAL NEUROREHAVILATION MARKET BY APPLICATIONS 2015-2024 ($ MILLION)

7.       GLOBAL STROKE APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

8.       GLOBAL TRAUMATIC BRAIN INJURY  APPLICATOIN MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL SPINAL CORD INJURY APPLCATION BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL PARKINSON’S  DISEASE  APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL CEREBRAL PALSY APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

12.   GLOBAL NEUROREHABILITATION DEVICES MARKET BY END USERS 2015-2024 ($ MILLION)

13.   GLOBAL COGNITIVE CARE CENTERS  END USER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

14.   GLOBAL HOSPITALS/CLINICS END USER  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

15.    GLOBAL OTHERS END USER  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

16.   NORTH AMERICA NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

17.   EUROPE NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

18.   ASIA PACIFIC NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

19.   REST OF THE WORLD NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

20.   NORTH AMERICA NEUROREHAVILATION MARKET BY PROVIDER 2015-2024 ($ MILLION)

21.   EUROPE NEUROREHAVILATION MARKET BY PROVIDER 2015-2024 ($ MILLION)

22.   ASIA PACIFIC NEUROREHAVILATION MARKET BY PROVIDER 2015-2024 ($ MILLION)

23.   REST OF THE WORLD FINTECH BLOCKCHAINMARKET BY PROVIDER 2015-2024 ($ MILLION)

24.   NORTH AMERICA NEUROREHAVILATION  MARKET BY PRODUCT 2015-2024 ($ MILLION)

25.   EUROPE NEUROREHAVILATION MARKET BY PRODUCT2015-2024 ($ MILLION)

26.   ASIA PACIFIC NEUROREHAVILATION  MARKET BY PRODUCT 2015-2024 ($ MILLION)

27.   REST OF THE WORLD NEUROREHAVILATION  MARKET BY APPLICATION 2015-2024 ($ MILLION)

28.   NORTH AMERICA NEUROREHAVILATION MARKET BY APPLICATIONS2015-2024 ($ MILLION)

29.   EUROPE NEUROREHAVILATION MARKET BY APPLICATIONS 2015-2024 ($ MILLION)

30.   ASIA PACIFIC NEUROREHAVILATION MARKET BY APPLICATIONS2015-2024 ($ MILLION)

31.   REST OF THE WORLD NEUROREHAVILATION MARKET BY APPLICATIONS2015-2024 ($ MILLION)

32.   NORTH AMERICA NEUROREHAVILATION MARKET BY END USERS2015-2024 ($ MILLION)

33.   EUROPE NEUROREHAVILATION MARKET BY END USERS2015-2024 ($ MILLION)

34.   ASIA PACIFIC NEUROREHAVILATION MARKET BY END USERS 2015-2024 ($ MILLION)

35.   REST OF THE WORLD NEUROREHAVILATION MARKET BY END USERS2015-2024 ($ MILLION)

36.   UNITED STATES NEUROREHAVILATION  MARKET BY PRODUCT 2015-2024 ($ MILLION)

37.   UNITED STATES NEUROREHAVILATION  MARKET BY APPLICATIONS2015-2024 ($ MILLION)

38.   UNITED STATES NEUROREHAVILATION  MARKET BY END USERS2015-2024 ($ MILLION)

39.   CANADA STATES NEUROREHAVILATION  MARKET BY PRODUCT 2015-2024 ($ MILLION)

40.   CANADA NEUROREHAVILATION  MARKET BY APPLICATIONS2015-2024 ($ MILLION)

41.   CANADA NEUROREHAVILATION  MARKET BY END USERS2015-2024 ($ MILLION)

42.   UK STATES NEUROREHAVILATION  MARKET BY PRODUCT 2015-2024 ($ MILLION)

43.   UK NEUROREHAVILATION  MARKET BY APPLICATIONS2015-2024 ($ MILLION)

44.   UK NEUROREHAVILATION  MARKET BY END USERS2015-2024 ($ MILLION)

45.   FRANCE STATES NEUROREHAVILATION  MARKET BY PRODUCT 2015-2024 ($ MILLION)

46.   FRANCE NEUROREHAVILATION  MARKET BY APPLICATIONS2015-2024 ($ MILLION)

47.   FRANCE NEUROREHAVILATION  MARKET BY END USERS2015-2024 ($ MILLION)

48.   GERMANY STATES NEUROREHAVILATION  MARKET BY PRODUCT 2015-2024 ($ MILLION)

49.   GERMANY NEUROREHAVILATION  MARKET BY APPLICATIONS2015-2024 ($ MILLION)

50.   GERMANY NEUROREHAVILATION  MARKET BY END USERS2015-2024 ($ MILLION)

LIST OF FIGURES

1.       GLOBAL NEUROREHAVILATION MARKET BY PRODUCT 2015-2024 ($ MILLION)

2.       GLOBAL NEUROROBOTIC SYSTEMS PRODUCT BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL BRAIN COMPUTER INTERFACE PRODUCTS MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL NON-INVASIVE STIMULATORS PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5.       GLOBAL WEARABLE DEVICE PRODUCT MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6.       GLOBAL NEUROREHAVILATION MARKET BY APPLICATIONS 2015-2024 ($ MILLION)

7.       GLOBAL STROKE APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

8.       GLOBAL TRAUMATIC BRAIN INJURY  APPLICATOIN MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL SPINAL CORD INJURY APPLCATION BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL PARKINSON’S  DISEASE  APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL CEREBRAL PALSY APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

12.   GLOBAL NEUROREHABILITATION DEVICES MARKET BY END USERS 2015-2024 ($ MILLION)

13.   GLOBAL COGNITIVE CARE CENTERS  END USER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

14.   GLOBAL HOSPITALS/CLINICS END USER  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

15.    GLOBAL OTHERS END USER  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

16.   UNITED STATES (U.S.) NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

17.   CANADA NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

18.   UNITED KINGDOM (UK) NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

19.   FRANCE NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

20.   GERMANY NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

21.   SPAIN NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

22.   ROE NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

23.   CHINA NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

24.   INDIA NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

25.   JAPAN NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

26.   AUSTRALIA NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

27.   ROAPAC NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

28.   LATIN AMERICA NEUROREHAVILATION MARKET 2015-2024 ($ MILLION)

29.   MENA NEUROREHAVILATION MARKET 2015-2024 ($ MILLION) 

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion